Skip to content

Lifestyle Modification and Potato Consumption

Lifestyle Modification and Potato Consumption

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01771926
Enrollment
107
Registered
2013-01-18
Start date
2013-02-28
Completion date
2016-06-30
Last updated
2018-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

resistant starch, lifestyle intervention

Brief summary

The investigators hypothesize that consumption of potatoes is a healthy adjunct to lifestyle intervention in overweight and obese glucose intolerant adults. We will evaluate the effects of the consumption of potatoes (high or low resistant starch) vs. commonly consumed carbohydrate sources on glucose tolerance; and ( the extent to which potato consumption alters markers of lipid metabolism and inflammation in the context of a lifestyle intervention program.

Detailed description

Our primary objective is to compare the effects of potato consumption to those of commonly consumed carbohydrate sources on glucose tolerance and other cardiometabolic risk factors in overweight and obese, glucose intolerant men and women participating in a lifestyle intervention program. We hypothesize that consumption of potatoes is a healthy adjunct to lifestyle intervention in overweight and obese glucose intolerant adults. Our specific aims include: (1) to evaluate of the effects of the consumption of potatoes (high or low resistant starch) vs. commonly consumed carbohydrate sources on glucose tolerance; and (2) to determine the extent to which potato consumption alters markers of lipid metabolism and inflammation in the context of a lifestyle intervention program.

Interventions

Daily intake of assigned treatment for 8 weeks

OTHERother carbohydrate

Daily intake of assigned treatment for 8 weeks

Sponsors

USDA Grand Forks Human Nutrition Research Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Men and women between 20-65 years of age. * Overweight or obese (BMI 25 - 39.9 Kg/m2) * Impaired Glucose Tolerance: fasting glucose between 100-125 mg/dL * Willingness to comply with the demands of the experimental protocol * Sedentary lifestyle

Exclusion criteria

* Major medical condition * Smokers * Unable to perform moderate exercise * Use of medications that alter glucose or lipid metabolism * Pregnant or lactating

Design outcomes

Primary

MeasureTime frame
Glucose ToleranceDays 0, 14, 28, 42, 56

Secondary

MeasureTime frame
Weight LossDays 0, 14, 28, 42, 56
Functional FitnessDays 0 and 57

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026